Topical gel composition for treatment of actinic keratosis and pharmaceutical use thereof
一种光化性角化病、凝胶组合物的技术,应用在药物组合、过敏性疾病、非有效成分的医用配制品等方向,达到高药理利用度、快速吸收或干燥的效果
Inactive Publication Date: 2015-08-12
ALMIRALL HERMAL
View PDF5 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
It has been found that topical administration of compositions comprising these levels of 5'-fluorouracil elicits a number of side effects
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreExamples
Experimental program
Comparison scheme
Effect test
example 1
[0042] A product with the following composition (wt%) was prepared:
[0043] 5'-Fluorouracil
example 2
[0045] A product with the following composition (wt%) was prepared:
[0046] 5'-Fluorouracil
example 3
[0048] A product with the following composition (wt%) was prepared:
[0049] 5'-Fluorouracil
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More
Abstract
The invention relates to a topical gel composition comprising (a) an active agent for treatment of actinic keratosis, (b) a keratolytically active agent, (c) a gel former and (d) an organic solvent for use in the treatment of actinic keratosis.
Description
[0001] This application is a divisional application of an invention patent application with an application date of June 29, 2009, an application number of "200980126663.5", and an invention title of "a topical composition for treating actinic keratosis". technical field [0002] The present invention relates to a topical composition useful as a medicine for the treatment of actinic keratoses. Background technique [0003] Actinic keratosis is a carcinoma in situ of the epidermis. It is associated with the proliferation of transformed keratinocytes confined to the epidermis, characterized by, inter alia, a high mutation rate of the tumor suppressor gene p53 and the telomerase gene. It is further associated with characteristic chromosomal aberrations that also commonly occur in invasive cutaneous squamous cell carcinoma. In about 10% of all patients with actinic keratoses, especially in about 30% of patients who are also immunosuppressed, the condition progresses to squamous ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/06A61K45/00A61K31/513A61K31/60A61K31/192A61P17/12
CPCA61K9/06A61K31/196A61K45/06A61K31/513A61K9/0014A61K31/60A61K47/32A61P17/00A61P17/02A61P17/12A61P35/00A61P37/02A61P43/00A61K2300/00
Inventor M·迈泽尔C·马蒂斯K·图德勒C·威勒斯H·马尔维茨
Owner ALMIRALL HERMAL
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com